Position in BMRN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$380,856
+$69,427 QoQ
Shares Held
6,656
+20.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#361
of 561 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethic Inc. holds $40,271,041 across 35 Biotechnology names. BMRN ranks #18 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,947 | $10,405,003 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,069 | $10,019,664 | |
| 3 | ARGX |
Argenx SE
|
4,376 | $4,059,921 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
31,679 | $2,511,827 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,965 | $1,615,628 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,172 | $1,556,927 | |
| 7 | MRNA |
Moderna, Inc.
|
15,694 | $1,099,050 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
9,345 | $885,438 |
All Filings in BMRN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380,856 | 6,656 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $311,429 | 5,513 | Shares | Sole | 2026-04-27 | |
| 2024-09-30 | $429,753 | 6,114 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $387,938 | 4,712 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $533,996 | 6,114 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $475,543 | 4,932 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $526,721 | 5,953 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $276,335 | 3,188 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $349,188 | 3,591 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $320,405 | 3,096 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||